SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011680
Filing Date
2021-05-17
Accepted
2021-05-17 08:00:50
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 335666
2 ex31-1.htm EX-31.1 11085
3 ex31-2.htm EX-31.2 11267
4 ex32-1.htm EX-32.1 10065
  Complete submission text file 0001493152-21-011680.txt   2715488

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20210331.xml EX-101.INS 402233
6 XBRL SCHEMA FILE cocp-20210331.xsd EX-101.SCH 35517
7 XBRL CALCULATION FILE cocp-20210331_cal.xml EX-101.CAL 47811
8 XBRL DEFINITION FILE cocp-20210331_def.xml EX-101.DEF 131273
9 XBRL LABEL FILE cocp-20210331_lab.xml EX-101.LAB 267407
10 XBRL PRESENTATION FILE cocp-20210331_pre.xml EX-101.PRE 209698
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 21927655
SIC: 2834 Pharmaceutical Preparations